US Patent Issued to ASCENTAGE PHARMA (SUZHOU) on April 8 for "Combination of immunotherapies with MDM2 inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., April 9 -- United States Patent no. 12,268,665, issued on April 8, was assigned to ASCENTAGE PHARMA (SUZHOU) Co. LTD (Suzhou, China).

"Combination of immunotherapies with MDM2 inhibitors" was invented by Dajun Yang (Suzhou, China), Yifan Zhai (Suzhou, China), Douglas Dong Fang (Suzhou, China) and Qiuqiong Tang (Suzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are combination therapies comprising an effective amount of a modulator of the immune checkpoint molecule; and an effective amount of a MDM2 inhibitor."

The patent was filed on Aug. 7, 2019, under Application No. 16/618,794.

*For further information, including images, charts and tables, please visit: http:...